Met Non Small Cell Cancer Registry (MOMENT)

Part of paid clinical trials in Fort Lauderdale, Florida.

Sponsor
EMD Serono Research & Development Institute, Inc.
Study ID
NCT05376891
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14(METex14) participants treated with systemic therapy.

Key Dates

Start date
Oct 4, 2022
Status verified
May 2026
Primary completion
Apr 28, 2028
Completion
Apr 28, 2028

Study Design

Enrollment
700 participants (estimated)

Arms

  • Arm: Advanced Non-small Cell Lung Cancer with METex14 skipping alterations
    Participants diagnosed with advanced NSCLC and who receive available therapies in routine clinical practice setting will be part of this registry. Data will be collected routinely from the point of enrollment of a participants into the registry until death, loss to follow-up (drop-out), subsequent enrollment into a clinical trial, or end of data collection period for the registry.

Primary Outcome Measure

Best Overall Response (BOR) [ Time Frame: Through study completion, up to approximately 4.9 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Holy Cross HealthFort LauderdaleFlorida33308-4603
David Drew (PRINCIPAL_INVESTIGATOR)
The Ohio State University Wexner Medical CenterColumbusOhio43221
David Carbone (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical CenterNashvilleTennessee37212-

Find similar trials in Fort Lauderdale, FL

By research site
Holy Cross Health· Fort Lauderdale, FLThe Ohio State University Wexner Medical Center· Columbus, OHVanderbilt University Medical Center· Nashville, TN

Related Studies